吉林大学学报(医学版) ›› 2017, Vol. 43 ›› Issue (06): 1186-1192.doi: 10.13481/j.1671-587x.20170622

• 临床研究 • 上一篇    下一篇

TM4SF1在乳腺癌组织中的表达及其临床意义

高新雅1, 张伟杰1, 崔黎2, 周学良1, 马志俊1, 吕转1, 池艳艳1, 王留兴1   

  1. 1. 郑州大学第一附属医院肿瘤科, 河南 郑州 450052;
    2. 郑州大学第一附属医院病理科, 河南 郑州 450052
  • 收稿日期:2017-05-16 出版日期:2017-11-28 发布日期:2017-12-01
  • 通讯作者: 王留兴,教授,硕士研究生导师(Tel:0371-66295532,E-mail:wlx2246@126.com) E-mail:wlx2246@126.com
  • 作者简介:高新雅(1991-),女,河南省南阳市人,在读医学硕士,主要从事肿瘤基础和临床方面的研究。
  • 基金资助:
    河南省教育厅高等学校重点科研项目资助课题(17A320057)

Expression of TM4SF1 in breast cancer tissue and its clinical significance

GAO Xinya1, ZHANG Weijie1, CUI Li2, ZHOU Xueliang1, MA Zhijun1, LYU Zhuan1, CHI Yanyan1, WANG Liuxing1   

  1. 1. Department of Oncology, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China;
    2. Department of Pathology, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
  • Received:2017-05-16 Online:2017-11-28 Published:2017-12-01

摘要: 目的:探讨四次跨膜蛋白1(TM4SF1)在乳腺癌组织中的表达情况,阐明其临床意义并初步探索其相关分子生物学机制。方法:收集190例人乳腺癌组织、110例癌旁组织和110例正常乳腺组织。免疫组织化学法检测乳腺癌组织、癌旁组织和正常乳腺组织中TM4SF1的表达,Western blotting法检测乳腺癌组织、癌旁组织和正常乳腺组织中TM4SF1的表达水平,RT-PCR法检测乳腺癌组织、癌旁组织和正常乳腺组织中TM4SF1mRNA的表达水平,检测不同临床病理特征乳腺癌患者乳腺癌组织中TM4SF1阳性表达率。结果:乳腺癌组织中TM4SF1阳性表达率高于癌旁组织和正常乳腺组织(P < 0.05),癌旁组织与正常乳腺组织中TM4SF1的阳性表达率比较差异无统计学意义(P=0.531);TM4SF1表达与患者年龄无明显关联,与肿块大小、分化程度、淋巴结转移和肿瘤分期有密切关联(P < 0.05);基底样型乳腺癌组织中TM4SF1阳性表达率高于其他3种病理类型(P < 0.05)。Western blotting法检测,乳腺癌组织中TM4SF1表达水平高于癌旁组织和正常乳腺组织(P < 0.05),癌旁组织与正常乳腺组织中TM4SF1表达水平比较差异无统计学意义(P > 0.05)。RT-PCR检测,乳腺癌组织中TM4SF1mRNA表达水平高于癌旁组织和正常乳腺组织(P < 0.01);癌旁组织与正常乳腺组织中TM4SF1mRNA的表达水平比较差异无统计学意义(P > 0.05)。结论:TM4SF1在乳腺癌组织中呈高表达,TM4SF1可能通过多种机制影响乳腺癌的发生发展及远处转移,提示TM4SF1可能成为乳腺癌治疗潜在的靶点。

关键词: 四次跨膜蛋白1, 免疫组织化学, 蛋白质免疫印迹, 乳腺肿瘤

Abstract: Objective:To investigate the expression of transmembrane 4 super family 1(TM4SF1) in breast cancer tissue,and to elucidate its clinical significance and explore the related molecular biological mechanisms. Methods:A total of 190 cases of human breast cancer, 110 cases of paracancerous tissue and 110 cases of normal breast tissue were collected. Immunohistochemistry was used to detect the expression levels of TM4SF1 mRNA in breast cancer tissue, paracancerous tissue, and normal breast tissue; Western blotting method was used to detect the expression levels of TM4SF1 in breast cancer tissue, paracancerous tissue, and normal breast tissue; RT-PCR method was used to detect the expression levels of TM4SF1 mRNA in breast cancer tissue, paracancerous tissue, and normal breast tissue. The positive expression rates of TM4SF1 in breast cancer tissue of the breast cancer patients with different clinicopathological features were detected. Results:The positive expression rate of TM4SF1 in the breast cancer tissue was significantly higher than those in paracancerous tissue and normal breast tissue (P < 0.05); there was no significant difference in the positive expression rates of TM4SF1 between paracancerous tissue and normal breast tissue (P=0.531);the expression of TM4SF1 was not correlated with age, but was closely correlated with tumor size, differentiation degree, lymph node metastasis and tumor stage (P < 0.05);the positive expression rate of TM4SF1 in basal like breast cancer tissue was higher than those in the other three types of tissues (P < 0.05). The results of Western blotting showed that the expression level of TM4SF1 in breast cancer tissue was higher than those in paracancerous tissue and normal breast tissue (P < 0.05),but there was no significant difference in the expression level of TM4SF1 between paracancerous tissue and normal breast tissue(P > 0.05). The results of RT-PCR showed that the expression level of TM4SF1 mRNA in breast cancer tissue was higher than those in the paracancerous tissue and normal breast tissue(P < 0.01);there was no significant difference in the expression level of TM4SF1 mRNA between paracancerous tissue and normal breast tissue(P > 0.05). Conclusion:The TM4SF1 is highly expressed in breast cancer tissue. TM4SF1 may affect the occurrence, development and distant metastasis of breast cancer through various mechanisms. TM4SF1 may be a potential target for the treatment of breast cancer.

Key words: transmembrane 4 super family 1, breast neoplasms, Western blotting, immunohistochemistry

中图分类号: 

  • R737.9